Clinical trial
Strategy Therapy on Early Phase Cancer Therapeutics-Related Cardiac Dysfunction Patients
NCT05892146 is registered in ClinicalTrials.gov with National Cheng-Kung University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Strategy Therapy on Early Phase Cancer Therapeutics-Related Cardiac Dysfunction Patients
- Lead sponsor
- National Cheng-Kung University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 5, 2021
- Completion date
- December 31, 2025
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, cardiotoxicity, chemotherapeutic toxicity, heart failure, lymphoma